{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:32:16Z","timestamp":1773322336510,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.vaccine.2009.04.027","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T08:45:36Z","timestamp":1241426736000},"page":"4038-4046","source":"Crossref","is-referenced-by-count":15,"title":["Neonatal vaccination with Mycobacterium bovis BCG: Potential effects as a priming agent shown in a heterologous prime-boost immunization protocol"],"prefix":"10.1016","volume":"27","author":[{"given":"Muhammad Jubayer","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2009.04.027_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.qco.0000168380.08895.9a","article-title":"Recent developments in tuberculosis vaccines","volume":"18","author":"Haile","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2009.04.027_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.vaccine.2009.04.027_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"1 Pt 1","key":"10.1016\/j.vaccine.2009.04.027_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.027_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF02751703","article-title":"BCG vaccination in India and tuberculosis in children: newer facets","volume":"61","author":"Udani","year":"1994","journal-title":"Indian J Pediatr"},{"issue":"9517","key":"10.1016\/j.vaccine.2009.04.027_bib6","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2009.04.027_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/IR:22:2-3:177","article-title":"T cell immunity in neonates","volume":"22","author":"Garcia","year":"2000","journal-title":"Immunol Res"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2009.04.027_bib8","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/S0264-410X(01)00028-7","article-title":"Neonatal and early life vaccinology","volume":"19","author":"Siegrist","year":"2001","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.04.027_bib9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0167-5699(99)01473-5","article-title":"T-cell function in newborn mice and humans","volume":"20","author":"Adkins","year":"1999","journal-title":"Immunol Today"},{"issue":"11","key":"10.1016\/j.vaccine.2009.04.027_bib10","doi-asserted-by":"crossref","first-page":"e3683","DOI":"10.1371\/journal.pone.0003683","article-title":"Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant","volume":"3","author":"Kamath","year":"2008","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.027_bib11","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1","article-title":"Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes","volume":"31","author":"Vekemans","year":"2001","journal-title":"Eur J Immunol"},{"issue":"9493","key":"10.1016\/j.vaccine.2009.04.027_bib12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.027_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/clinids\/20.1.126","article-title":"Relationship between bacille Calmette-Gu\u00e9rin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis","volume":"20","author":"Brewer","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.04.027_bib14","series-title":"Issues relating to the use of BCG in immunization programmes","author":"Fine","year":"1999"},{"issue":"8","key":"10.1016\/j.vaccine.2009.04.027_bib15","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.04.027_bib16","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.027_bib17","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.4049\/jimmunol.178.6.3721","article-title":"Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection","volume":"178","author":"Dietrich","year":"2007","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.04.027_bib18","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1128\/IAI.72.12.6799-6805.2004","article-title":"The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis","volume":"72","author":"Parra","year":"2004","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.04.027_bib19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nm1090","article-title":"Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin","volume":"10","author":"Temmerman","year":"2004","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.027_bib20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.184.3.993","article-title":"Identification of a heparin-binding hemagglutinin present in mycobacteria","volume":"184","author":"Menozzi","year":"1996","journal-title":"J Exp Med"},{"issue":"6843","key":"10.1016\/j.vaccine.2009.04.027_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.027_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/338833","article-title":"Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis","volume":"185","author":"Masungi","year":"2002","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2009.04.027_bib23","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.027_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.femsim.2005.02.009","article-title":"Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis","volume":"45","author":"Giri","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"15","key":"10.1016\/j.vaccine.2009.04.027_bib25","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","article-title":"Mucosal adjuvants","volume":"23","author":"Freytag","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.027_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunol Lett."},{"issue":"8","key":"10.1016\/j.vaccine.2009.04.027_bib27","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.4049\/jimmunol.179.8.5346","article-title":"The acquired immune response to the mucosal adjuvant LTK63 imprints the mouse lung with a protective signature","volume":"179","author":"Tritto","year":"2007","journal-title":"J Immunol."},{"issue":"24","key":"10.1016\/j.vaccine.2009.04.027_bib28","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1128\/JB.181.24.7464-7469.1999","article-title":"Functional domains present in the mycobacterial hemagglutinin, HBHA","volume":"181","author":"Delogu","year":"1999","journal-title":"J Bacteriol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.04.027_bib29","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.4049\/jimmunol.167.11.6453","article-title":"IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection","volume":"167","author":"Rothfuchs","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.027_bib30","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.027_bib31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.027_bib32","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1128\/IAI.74.5.3006-3011.2006","article-title":"The hbhA gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice","volume":"74","author":"Delogu","year":"2006","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2009.04.027_bib33","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.vaccine.2007.12.005","article-title":"Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) in infected mice","volume":"26","author":"Kohama","year":"2008","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2009.04.027_bib34","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2005.12.066","article-title":"Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv","volume":"24","author":"Romano","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.027_bib35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1086\/499953","article-title":"Bacille Calmette-Gu\u00e9rin vaccine-induced disease in HIV-infected and HIV-uninfected children","volume":"42","author":"Hesseling","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.027_bib36","first-page":"47","article-title":"Second IUATLD study on complications induced by intradermal BCG vaccination","volume":"63","author":"Lotte","year":"1988","journal-title":"Bull Int Union Tuberc Lung Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2009.04.027_bib37","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice","volume":"181","author":"Forbes","year":"2008","journal-title":"J Immunol"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2009.04.027_bib38","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.vaccine.2003.08.017","article-title":"Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C","volume":"22","author":"Mazzantini","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.027_bib39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.188.5.845","article-title":"Recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies","volume":"188","author":"Matsumoto","year":"1998","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.027_bib40","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.4049\/jimmunol.158.4.1742","article-title":"Differential responses to challenge with live and dead Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin","volume":"158","author":"Chambers","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.04.027_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1479-0556-5-7","article-title":"Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming","volume":"5","author":"Gon\u00e7alves","year":"2007","journal-title":"Genet Vaccines Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09005714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09005714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:35:23Z","timestamp":1684974923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09005714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":41,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0264410X09005714"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.04.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}